Product Images Dexmethylphenidate Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Dexmethylphenidate Hydrochloride NDC 10702-108 by Kvk-tech, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This table presents efficacy results from a study on the treatment of ADHD in pediatric patients aged 6-17 years. The primary efficacy measure was the Teacher SNAP-ADHD Total Score, and the table summarizes the Mean Baseline Score, Mean change from baseline to week 4, and Week 4 Score for the Treatment Group (n=42) and Placebo Group (n=41). The results show a statistically significant difference between the two groups, with the Treatment Group demonstrating greater improvement in symptoms.*
This is a summary of the efficacy results from a randomized withdrawal study focusing on attention deficit hyperactivity disorder (ADHD) treatment in pediatric patients aged 6 to 17. The study (Study 2) compares the proportion of treatment failures between the Focalin 5-20mg/day treatment group and placebo. Out of the 35 randomized patients, 6 (17.1%) failed in the Focalin group while 25/40 (62.5%) failed in the placebo group. The Focalin treatment was statistically significantly better than the placebo.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.